JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS
SEPTEMBER 2014
12:30 – 1:30 PM
BLOCK AMPHITHEATRE
*September 8
WOMEN AND CARDIOVASCULAR DISEASE: IS THERE A SEX DIFFERENCE?
Martha Gulati, MD, MS, FACC, FAHA
Associate Director of Women’s Academic Advancement for FAME (Faculty Advancement, Mentoring and Engagement) at the OSU College of Medicine
Associate Professor of Medicine in the Division of Cardiology
Associate Professor of Clinical Public Health, Division of Epidemiology
Sarah Ross Soter Chair in Women’s Cardiovascular Health
Section Director for Preventive Cardiology and Women’s Cardiovascular Health
The Ohio State University, Columbus, Ohio
1. Review the sex differences in presentation, cardiovascular risk factors, diagnosis and treatment of cardiovascular disease
2. Understand the differences in coronary artery disease patterns in women (Female-Specific Ischemic Heart Disease) and its impact on prognosis
3. Discuss the latest research in treatment and diagnosis of cardiovascular disease in women
4. Discuss and review the Guidelines in Heart Disease Prevention& Stroke Prevention in Women and its impact on assessing a woman’s risk
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology, Tel. 514-340-8222 ext. 2992.
THE ROLE OF THE KIDNEYS IN DIABETES: FOCUS ON SGLT-2 INHIBITOR
Stavroula Christopoulos, MD
Assistant Professor of Medicine, McGill University
Division of Endocrinology, Jewish General Hospital
1. Describe the mechanism for the reabsorption of glucose in the kidneys
2. Describe the SGLT2 inhibitors (sodium/glucose cotransporter 2), their mode of action and their pharmacodynamic effects
3. Discuss the role of SGLT2 inhibitors in the treatment of type 2 diabetes
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 3976.
26th ANNUAL BERTHA & NACHUM MIZNE MEMORIAL LECTURE
LACTOSE, LACTASE, EVOLUTION AND POSSIBLE IMPACT ON MODERN DISEASES
Andrew Szilagyi, MD
Assistant Professor of Medicine, McGill University
Division of Gastroenterology, Jewish General Hospital
1. To understand the current concept of lactose intolerance and the distinction from lactose maldigestion
2. To understand the principle of lactose adaptation and the possible role in reducing or increasing risk of different diseases purportedly related to dairy food consumption
3. To examine the concept that the evolution of lactase persistence together with population migrations before and after helped to shape geographic patterns of some modern day diseases
Contact Person: E. L. Schiffrin, MD, Chief, Department of Medicine, Tel. 514-340-7538.
THE MCGILL INTERNAL MEDICINE GLOBAL HEALTH INITIATIVE: HAITI 2014
Robert Battat, MD
Internal Medicine Resident, PGY3
McGill University & Jewish General Hospital
Internal Medicine Resident, PGY3, McGill University
Nephrology Fellow, PGY4, University of Toronto
Introduction to
1. New Global Health Elective for Internal Medicine in Haiti.
2. Resident global health competency development as a tool to improve clinical acumen, patient care, physical exam, health advocacy and a broader “systems-based” view of healthcare.
3. Staff as role models to residents and potential staff roles in the future
Contact Person: Ruxandra Bunea, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 x 4974.
*Lunch will be provided on September 8 and 15, 2014.
Please bring your own lunch on September 22 and 29, 2014.
Jul82014914